贝泰妮：云南贝泰妮生物科技集团股份有限公司2024年半年度报告_英文版.PDF

1、Yunnan Botanee Bio-Technology Group Co.LTD Full Text of the 2024 Semi-annual Report Yunnan Botanee Bio-Technology Group Co.LTD 2024 Semi-annual Report 2024-040 August 2024 Yunnan Botanee Bio-Technology Group Co.LTD Full Text of the 2024 Semi-annual Report 2 Section I Important Notice,Table of Conten

2、ts,and Definitions Our Board of Directors,Board of Supervisors,directors,supervisors,and senior managers guarantee that this semi-annual report is true,accurate and complete without falsehoods,misleading statements or major omissions,and undertake individual and joint legal liabilities arising there

3、from.Our Chairman and President Guo Zhenyu,Chief Financial Officer(CFO)Wang Long,and Head of Accounting Department Liu Zhaofeng hereby declare that the financial report herein is true,accurate,and complete.All directors of Botanee have attended the board meeting for deliberating on this semi-annual

4、report.Forward-looking statements herein on Botanees future prospects,business plans,etc.do not constitute substantial commitments to investors.Investors are advised to read carefully such information,and watch investment risks.Investors and related parties should maintain adequate risk awareness,an

5、d understand the differences between plans,forecasts,and commitments.We have described in detail possible risks in our operations in“10.Risks and Countermeasures of Botanee”of“Section III Discussion and Analysis by the Management”of this report.Investors are kindly requested to pay attention to thes

6、e sections.The Company shall comply with the disclosure requirements for Retail Industry and“Chemical Industry-related Business”as stated in the Self-regulatory Guidelines for Listed Companies of Shenzhen Stock Exchange No.3-Industry Information Disclosure,and the disclosure requirements for“E-comme